Degradation of AMPK by a cancer-specific ubiquitin ligase

Cell

Volumn 160, Issue 4, 2015, Pages 715-728

  Pineda, Carlos T ^a   Ramanathan, Saumya ^a   Fon Tacer, Klementina ^a   Weon, Jenny L ^a   Potts, Malia B ^a   Ou, Yi Hung ^a   White, Michael A ^a   Potts, Patrick Ryan ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; AMP KINASE ALPHA1; MAMMALIAN TARGET OF RAPAMYCIN; MELANOMA ANTIGEN 3; METFORMIN; PROTEIN MAGE A6; PROTEIN TRIM28; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAGEA3 PROTEIN, HUMAN; MAGEA3 PROTEIN, MOUSE; MAGEA6 PROTEIN, HUMAN; MAGEA6 PROTEIN, MOUSE; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CANCER CELL; CARCINOGENESIS; CELL ENERGY; CELL VIABILITY; CONTROLLED STUDY; ENERGY BALANCE; ENZYME DEGRADATION; ENZYME REPRESSION; GERM LINE; HOMEOSTASIS; HUMAN; HUMAN CELL; METABOLIC STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; ENERGY METABOLISM; GENETICS; MALE; METABOLISM; NEOPLASM; SEQUENCE ALIGNMENT; TESTIS;

AMINO ACID SEQUENCE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIGENS, NEOPLASM; ENERGY METABOLISM; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASMS; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TESTIS;

EID: 84922689340     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.01.034     Document Type: Article

References (67)

1. K. Barnes, J.C. Ingram, O.H. Porras, L.F. Barros, E.R. Hudson, L.G. Fryer, F. Foufelle, D. Carling, D.G. Hardie, and S.A. Baldwin Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK) J. Cell Sci. 115 2002 2433 2442
2. Cancer Genome Atlas Research Network Comprehensive molecular profiling of lung adenocarcinoma Nature 511 2014 543 550 Erratum in Nature 2014;514:262. Rogers, K [corrected to Rodgers, K]
3. C. Cantó, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, J.C. Milne, P.J. Elliott, P. Puigserver, and J. Auwerx AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
4. D. Carling, V.A. Zammit, and D.G. Hardie A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis FEBS Lett. 223 1987 217 222
5. A.M. Choi, S.W. Ryter, and B. Levine Autophagy in human health and disease N. Engl. J. Med. 368 2013 651 662
6. P. Chomez, O. De Backer, M. Bertrand, E. De Plaen, T. Boon, and S. Lucas An overview of the MAGE gene family with the identification of all human members of the family Cancer Res. 61 2001 5544 5551
7. C.C. Chou, K.H. Lee, I.L. Lai, D. Wang, X. Mo, S.K. Kulp, C.L. Shapiro, and C.S. Chen AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis Cancer Res. 74 2014 4783 4795
8. B. Cool, B. Zinker, W. Chiou, L. Kifle, N. Cao, M. Perham, R. Dickinson, A. Adler, G. Gagne, and R. Iyengar Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome Cell Metab. 3 2006 403 416
9. E. De Plaen, K. Arden, C. Traversari, J.J. Gaforio, J.P. Szikora, C. De Smet, F. Brasseur, P. van der Bruggen, B. Lethé, and C. Lurquin Structure, chromosomal localization, and expression of 12 genes of the MAGE family Immunogenetics 40 1994 360 369
10. J.M. Doyle, J. Gao, J. Wang, M. Yang, and P.R. Potts MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases Mol. Cell 39 2010 963 974
11. D.F. Egan, D.B. Shackelford, M.M. Mihaylova, S. Gelino, R.A. Kohnz, W. Mair, D.S. Vasquez, A. Joshi, D.M. Gwinn, and R. Taylor Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy Science 331 2011 456 461
12. R. Esteve-Puig, F. Canals, N. Colomé, G. Merlino, and J.A. Recio Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF PLoS ONE 4 2009 e4771
13. B. Faubert, G. Boily, S. Izreig, T. Griss, B. Samborska, Z. Dong, F. Dupuy, C. Chambers, B.J. Fuerth, and B. Viollet AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo Cell Metab. 17 2013 113 124
14. Y. Feng, J. Gao, and M. Yang When MAGE meets RING: insights into biological functions of MAGE proteins Protein Cell 2 2011 7 12
15. D.M. Gwinn, D.B. Shackelford, D.F. Egan, M.M. Mihaylova, A. Mery, D.S. Vasquez, B.E. Turk, and R.J. Shaw AMPK phosphorylation of raptor mediates a metabolic checkpoint Mol. Cell 30 2008 214 226
16. S.M. Hadad, L. Baker, P.R. Quinlan, K.E. Robertson, S.E. Bray, G. Thomson, D. Kellock, L.B. Jordan, C.A. Purdie, and D.G. Hardie Histological evaluation of AMPK signalling in primary breast cancer BMC Cancer 9 2009 307
17. S. Hadad, T. Iwamoto, L. Jordan, C. Purdie, S. Bray, L. Baker, G. Jellema, S. Deharo, D.G. Hardie, and L. Pusztai Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial Breast Cancer Res. Treat. 128 2011 783 794
18. Y.H. Hao, J.M. Doyle, S. Ramanathan, T.S. Gomez, D. Jia, M. Xu, Z.J. Chen, D.D. Billadeau, M.K. Rosen, and P.R. Potts Regulation of WASH-dependent actin polymerization and protein trafficking by ubiquitination Cell 152 2013 1051 1064
19. D.G. Hardie, and D.R. Alessi LKB1 and AMPK and the cancer-metabolism link - ten years after BMC Biol. 11 2013 36
20. D.G. Hardie, F.A. Ross, and S.A. Hawley AMP-activated protein kinase: a target for drugs both ancient and modern Chem. Biol. 19 2012 1222 1236
21. D.G. Hardie, F.A. Ross, and S.A. Hawley AMPK: a nutrient and energy sensor that maintains energy homeostasis Nat. Rev. Mol. Cell Biol. 13 2012 251 262
22. S.A. Hawley, J. Boudeau, J.L. Reid, K.J. Mustard, L. Udd, T.P. Mäkelä, D.R. Alessi, and D.G. Hardie Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade J. Biol. 2 2003 28
23. S.A. Hawley, D.A. Pan, K.J. Mustard, L. Ross, J. Bain, A.M. Edelman, B.G. Frenguelli, and D.G. Hardie Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase Cell Metab. 2 2005 9 19
24. K. Imamura, T. Ogura, A. Kishimoto, M. Kaminishi, and H. Esumi Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line Biochem. Biophys. Res. Commun. 287 2001 562 567
25. K. Inoki, T. Zhu, and K.L. Guan TSC2 mediates cellular energy response to control cell growth and survival Cell 115 2003 577 590
26. S.J. Jang, J.C. Soria, L. Wang, K.A. Hassan, R.C. Morice, G.L. Walsh, W.K. Hong, and L. Mao Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis Cancer Res. 61 2001 7959 7963
27. R.G. Jones, D.R. Plas, S. Kubek, M. Buzzai, J. Mu, Y. Xu, M.J. Birnbaum, and C.B. Thompson AMP-activated protein kinase induces a p53-dependent metabolic checkpoint Mol. Cell 18 2005 283 293
28. J. Kim, M. Kundu, B. Viollet, and K.L. Guan AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 Nat. Cell Biol. 13 2011 132 141
29. J. Kim, Y.C. Kim, C. Fang, R.C. Russell, J.H. Kim, W. Fan, R. Liu, Q. Zhong, and K.L. Guan Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy Cell 152 2013 290 303
30. K.R. Laderoute, J.M. Calaoagan, W.R. Chao, D. Dinh, N. Denko, S. Duellman, J. Kalra, X. Liu, I. Papandreou, L. Sambucetti, and L.G. Boros 5′-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumors J. Biol. Chem. 289 2014 22850 22864
31. R.R. Landgraf, D. Goswami, F. Rajamohan, M.S. Harris, M.F. Calabrese, L.R. Hoth, R. Magyar, B.D. Pascal, M.J. Chalmers, and S.A. Busby Activation of AMP-activated protein kinase revealed by hydrogen/deuterium exchange mass spectrometry Structure 21 2013 1942 1953
32. C.W. Lee, L.L. Wong, E.Y. Tse, H.F. Liu, V.Y. Leong, J.M. Lee, D.G. Hardie, I.O. Ng, and Y.P. Ching AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells Cancer Res. 72 2012 4394 4404
33. J. Liang, S.H. Shao, Z.X. Xu, B. Hennessy, Z. Ding, M. Larrea, S. Kondo, D.J. Dumont, J.U. Gutterman, and C.L. Walker The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis Nat. Cell Biol. 9 2007 218 224
34. W. Liu, S. Cheng, S.L. Asa, and S. Ezzat The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis Cancer Res. 68 2008 8104 8112
35. L. Marcar, N.J. Maclaine, T.R. Hupp, and D.W. Meek Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin Cancer Res. 70 2010 10362 10370
36. S. Matsumoto, R. Iwakawa, K. Takahashi, T. Kohno, Y. Nakanishi, Y. Matsuno, K. Suzuki, M. Nakamoto, E. Shimizu, J.D. Minna, and J. Yokota Prevalence and specificity of LKB1 genetic alterations in lung cancers Oncogene 26 2007 5911 5918
37. M. Monte, M. Simonatto, L.Y. Peche, D.R. Bublik, S. Gobessi, M.A. Pierotti, M. Rodolfo, and C. Schneider MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents Proc. Natl. Acad. Sci. USA 103 2006 11160 11165
38. M. Nakamura, S. Okinaga, and K. Arai Metabolism of round spermatids: evidence that lactate is preferred substrate Am. J. Physiol. 247 1984 E234 E242
39. S. Niraula, R.J. Dowling, M. Ennis, M.C. Chang, S.J. Done, N. Hood, J. Escallon, W.L. Leong, D.R. McCready, and M. Reedijk Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study Breast Cancer Res. Treat. 135 2012 821 830
40. I. Pernicova, and M. Korbonits Metformin - mode of action and clinical implications for diabetes and cancer Nat. Rev. Endocrinol. 10 2014 143 156
41. B.J. Quinn, H. Kitagawa, R.M. Memmott, J.J. Gills, and P.A. Dennis Repositioning metformin for cancer prevention and treatment Trends Endocrinol. Metab. 24 2013 469 480
42. A.I. Roig, U. Eskiocak, S.K. Hight, S.B. Kim, O. Delgado, R.F. Souza, S.J. Spechler, W.E. Wright, and J.W. Shay Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro Gastroenterology 138 2010 1012 1021 e1011-1015
43. M. Sanchez-Cespedes, P. Parrella, M. Esteller, S. Nomoto, B. Trink, J.M. Engles, W.H. Westra, J.G. Herman, and D. Sidransky Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung Cancer Res. 62 2002 3659 3662
44. D.B. Shackelford, and R.J. Shaw The LKB1-AMPK pathway: metabolism and growth control in tumour suppression Nat. Rev. Cancer 9 2009 563 575
45. D.B. Shackelford, D.S. Vasquez, J. Corbeil, S. Wu, M. Leblanc, C.L. Wu, D.R. Vera, and R.J. Shaw mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome Proc. Natl. Acad. Sci. USA 106 2009 11137 11142
46. H.M. Shantha Kumara, M.J. Grieco, O.L. Caballero, T. Su, A. Ahmed, E. Ritter, S. Gnjatic, V. Cekic, L.J. Old, and A.J. Simpson MAGE-A3 is highly expressed in a subset of colorectal cancer patients Cancer Immun. 12 2012 16
47. R.J. Shaw, M. Kosmatka, N. Bardeesy, R.L. Hurley, L.A. Witters, R.A. DePinho, and L.C. Cantley The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress Proc. Natl. Acad. Sci. USA 101 2004 3329 3335
48. A.J. Simpson, O.L. Caballero, A. Jungbluth, Y.T. Chen, and L.J. Old Cancer/testis antigens, gametogenesis and cancer Nat. Rev. Cancer 5 2005 615 625
49. M. Suter, U. Riek, R. Tuerk, U. Schlattner, T. Wallimann, and D. Neumann Dissecting the role of 5′-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase J. Biol. Chem. 281 2006 32207 32216
50. M.C. Towler, S. Fogarty, S.A. Hawley, D.A. Pan, D.M. Martin, N.A. Morrice, A. McCarthy, M.N. Galardo, S.B. Meroni, and S.B. Cigorraga A novel short splice variant of the tumour suppressor LKB1 is required for spermiogenesis Biochem. J. 416 2008 1 14
51. C. Wang, A. Ivanov, L. Chen, W.J. Fredericks, E. Seto, F.J. Rauscher 3rd, and J. Chen MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation EMBO J. 24 2005 3279 3290
52. J. Weber, M. Salgaller, D. Samid, B. Johnson, M. Herlyn, N. Lassam, J. Treisman, and S.A. Rosenberg Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine Cancer Res. 54 1994 1766 1771
53. P. Weber, F. Cammas, C. Gerard, D. Metzger, P. Chambon, R. Losson, and M. Mark Germ cell expression of the transcriptional co-repressor TIF1beta is required for the maintenance of spermatogenesis in the mouse Development 129 2002 2329 2337
54. Y. Wei, Z. Zou, N. Becker, M. Anderson, R. Sumpter, G. Xiao, L. Kinch, P. Koduru, C.S. Christudass, and R.W. Veltri EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance Cell 154 2013 1269 1284
55. I.B. Weinstein Cancer. Addiction to oncogenes - the Achilles heal of cancer Science 297 2002 63 64
56. E. White Deconvoluting the context-dependent role for autophagy in cancer Nat. Rev. Cancer 12 2012 401 410
57. W.W. Winder, B.F. Holmes, D.S. Rubink, E.B. Jensen, M. Chen, and J.O. Holloszy Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle J. Appl. Physiol. 88 2000 2219 2226
58. S.N. Wingo, T.D. Gallardo, E.A. Akbay, M.C. Liang, C.M. Contreras, T. Boren, T. Shimamura, D.S. Miller, N.E. Sharpless, and N. Bardeesy Somatic LKB1 mutations promote cervical cancer progression PLoS ONE 4 2009 e5137
59. A. Woods, K. Dickerson, R. Heath, S.P. Hong, M. Momcilovic, S.R. Johnstone, M. Carlson, and D. Carling Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells Cell Metab. 2 2005 21 33
60. B. Yang, S.M. O'Herrin, J. Wu, S. Reagan-Shaw, Y. Ma, K.M. Bhat, C. Gravekamp, V. Setaluri, N. Peters, and F.M. Hoffmann MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines Cancer Res. 67 2007 9954 9962
61. B. Zheng, J.H. Jeong, J.M. Asara, Y.Y. Yuan, S.R. Granter, L. Chin, and L.C. Cantley Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation Mol. Cell 33 2009 237 247
62. L. Zheng, W. Yang, F. Wu, C. Wang, L. Yu, L. Tang, B. Qiu, Y. Li, L. Guo, and M. Wu Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma Clin. Cancer Res. 19 2013 5372 5380
63. A.L. Bookout, C.L. Cummins, D.J. Mangelsdorf, J.M. Pesola, and M.F. Kramer High-throughput real-time quantitative reverse transcription PCR Curr. Protoc. Mol. Biol. Chapter 15 2006 Unit 15 18
64. A.L. Bookout, Y. Jeong, M. Downes, R.T. Yu, R.M. Evans, and D.J. Mangelsdorf Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network Cell 126 2006 789 799
65. K. Fon Tacer, A.L. Bookout, X. Ding, H. Kurosu, G.B. John, L. Wang, R. Goetz, M. Mohammadi, M. Kuro-o, D.J. Mangelsdorf, and S.A. Kliewer Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse Mol. Endocrinol. 24 2010 2050 2064
66. R.D. Ramirez, S. Sheridan, L. Girard, M. Sato, Y. Kim, J. Pollack, M. Peyton, Y. Zou, J.M. Kurie, and J.M. Dimaio Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins Cancer Res. 64 2004 9027 9034
67. M. Sato, M.B. Vaughan, L. Girard, M. Peyton, W. Lee, D.S. Shames, R.D. Ramirez, N. Sunaga, A.F. Gazdar, J.W. Shay, and J.D. Minna Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells Cancer Res. 66 2006 2116 2128